Journals / Bakırköy Tıp Dergisi / 2009 / Cilt: 5 - Sayı: 4

Rarely seen prostate tumour: Prostate small cell neuroendocrine carcinoma

Nadir görülen bir prostat tümörü: Prostat küçük hücreli nöroendokrin karsinom

Pages
170–172
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Then the microscope slides of prostate of this patient were consulted in another pathology laboratory and reported as small cell neuro-endocrine carsinoma.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Neuroendocrine cells are plentiful in the prostate and are diffusely distributed throughout the organ at birth.
📊
Key Findings & Data:The patient’s laboratory examination revealed a PSA serum level values 4 ng/ml.
💡
Conclusion & Impact:Then the microscope slides of prostate of this patient were consulted in another pathology laboratory and reported as small cell neuro-endocrine carsinoma.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Erkek · Karsinom · nöroendokrin

Abstract

Neuroendocrine cells are plentiful in the prostate and are diffusely distributed throughout the organ at birth. The patient’s laboratory examination revealed a PSA serum level values 4 ng/ml. Then, transrectal ultrasound-guided 10-core biyopsy of prostate was performed revealing prostate adenecarcinoma with gleason score 5+3 and peri-neural invasion. The patient applied to our policlinic and underwent laboratory examination with a PSA serum level values 0.45 ng/ml. Then the microscope slides of prostate of this patient were consulted in another pathology laboratory and reported as small cell neuro-endocrine carsinoma.

Özet

Nöroendokrin hücreler prostat dokusunda bol olarak bulunur ve doğumda prostat içerisinde yaygın dağılım gösterirler. Bu olgu sunumundaki hastada yapılan incelemelerde PSA 4 ng/ml bulunmuş ve sonrasında transrektal ultrasonografi (TRUS) eşliğinde 10 kadran iğne biyopsisi alınmış ve patolojik incelemesinde prostat adenokarsinom, Gleason skor 5+3= 8 ve perinöral invazyon mevcut olarak değerlendirilmiş. Polikliniğimizde görülen hastanın PSA’sının 0.45 ng/ml olarak tespit edilmesi nedeniyle patoloji preparatları başka bir patoloji labratuvarında değerlendirilmek üzere konsültasyon istendi ve tekrar inceleme sonucunda olgu küçük hücreli nöroendokrin karsinom olarak değerlendirilmiştir.

🔖

Cite This Article

KARADAĞ, S., KALFAZADE, N., ARAS, B., GÜRBÜZ, N., ÖZBAY, B., TAŞÇI, A. İ. (2009). Rarely seen prostate tumour: Prostate small cell neuroendocrine carcinoma. Bakırköy Tıp Dergisi, Cilt: 5 - Sayı: 4, 170–172. https://ajindex.com/articles/132951

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Epstein JI. Pathology of prostatic neoplasia. In: Walsh P, Retik AB, Vaughan ED (Eds). Campbell’s Urology. Philadelphia; Elsewier, 2007: p.2880
  2. Bostwick DG (Ed). Neoplazm of the prostate. In: Urologic Surgical Pathology. St. Louis; Mosby-Year Book, 1997: p.343
  3. Cohen RJ, Glezerson G, Haffejee Z, et al. Prostatic carcinoma: histological and immunohistological factors affecting prognosis. Br J Urol 1990; 66: 405-410. 4. di Sant'Agnese PA. Neuoroendocrine differentiation in human prostatic carcinoma. Hum Patol 1992; 23: 287-296
  4. Burchardt T, Burchardt M, Chen MW, et al. Transdifferentiation of prostat cancer cells to a neoroendocrine cell phenotype in vitro and in vivo. J Urol 1999; 162: 1800-1805
  5. Fetissof F, Dubois MP, Arbeille-Brassart B, Lanson Y, Boivin F, Jobard P. Endocrine cells in prostate gland, urethelium and brenner tumors: immunohistological and ultrastructural studies. Virchows Arch B Cell Pathol Incl Mol Pathol 1993; 42: 53-64
  6. Wu JT, Astill ME, Liu GH, Stephenson RA. Serum chromogranin A: early detection of hormonal resistance in prostate cancer patients. J Clin Lab Anal 1998; 12: 20-25
  7. Diaz M, Abdul M, Hoosein N. Modulation of neuroendocrine differentiation in prostate cancer by interleukin-1 and-2. Prostate Suppl 1998; 8: 32-36. 9. di Santagnese PA. Divergent neuroendocrine diffentiation in prostatic carcinoma. Semin Diagn Pathol 2000; 17: 144-161.